A.C.L.U. Warns Against Fever-Screening Tools for Coronavirus

Airports, office buildings, warehouses and restaurant chains are rushing to install new safety measures like fever-scanning cameras and infrared temperature-sensing guns. But the American Civil Liberties Union warned on Tuesday against using the tools to screen people for possible coronavirus symptoms, saying the devices were often inaccurate, ineffective and intrusive. In a new report, “Temperature…

Details

Germany and France Propose $545 Billion Coronavirus Fund for Europe

Here’s what you need to know: Video Chancellor Angela Merkel of Germany and President Emmanuel Macron of France proposed a $545 billion joint fund for European Union members hit hard by coronavirus.CreditCredit…Pool photo by Andreas Gora Merkel and Macron pitch a ‘one-off’ borrowing plan to help Europe’s hardest-hit countries. Faced with economic calamity and the…

Details

What to Know About Hydroxychloroquine

President Trump revealed on Monday that he had been taking an anti-malaria drug as a preventive measure against the coronavirus, the same medicine that he has been promoting for two months with scant evidence of its efficacy and despite several warnings of dangerous side effects. The drug, hydroxychloroquine, has been invoked by Mr. Trump repeatedly…

Details

Researchers urge clinical trial of blood pressure drug to prevent complication of Covid-19

Researchers in the Ludwig Center at the Johns Hopkins Kimmel Cancer Center report they have identified a drug treatment that could–if given early enough–potentially reduce the risk of death from the most serious complication of Coronavirus disease 2019 (COVID-19), also known as SARS-CoV-2 infection. Prazosin, a U.S. Food and Drug Administration-approved alpha blocker that relaxes…

Details

Researchers find potential drug treatment targets for alcohol-related liver disease

Alcohol-related liver disease (ALD) is a deadly condition affecting more than 150 million people worldwide with no treatment available besides transplant. But now, a team led by researchers from Massachusetts General Hospital (MGH) has uncovered key molecular step stones in ALD that may provide targets for drug therapy development. Their work was recently published in…

Details

Mount Sinai Health System and Renalytix form joint venture, Kantaro Biosciences, to develop and scale production of COVID antibody test kits

Mount Sinai Health System (“Mount Sinai”) and Renalytix AI (LSE: RENX) today announced the formation of Kantaro Biosciences, LLC (“Kantaro”), a Mount Sinai venture, to develop and scale production and distribution of a test kit based on the Mount Sinai-developed high-performance serologic assay for SARS-CoV-2 antibodies. Kantaro has partnered with Minneapolis-based Bio-Techne Corporation (NASDAQ: TECH)…

Details